Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
Citation
Lawrence, M, Obinata, D, Sandhu, S et al 2018, 'Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy', European Urology, vol. 74, no. 5, pp. 562-572.Year
2018ANU Authors
Fields of Research
- Cancer Cell Biology
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)